References
- Adachi Y, Reynolds P N, Yamamoto M, et al. (2001). A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging. Cancer Res, 61, 7882-8.
- Antunes G, Neville E. (2000). Management of malignant pleural effusions. Thorax, 55, 981-3. https://doi.org/10.1136/thorax.55.12.981
- Benlloch S, Galbis-Caravajal J.M, Martin C, et al. (2006). Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer, 107, 1859-65. https://doi.org/10.1002/cncr.22190
- Davidson B. (2004). Malignant effusions: from diagnosis to biology. Diagnostic cytopathology, 31, 246-54. https://doi.org/10.1002/dc.20133
- Fiegl M. (2005). The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion. Curr Opin Pulm Med, 11, 313-8. https://doi.org/10.1097/01.mcp.0000166491.92659.5e
- Fishman AP, Fishman JAE, Grippi MA (2008). Malignant Pleural Effuions. In Fishman's pulmonary diseases and disorders (A.P. Fishman ed.). pp. 1506-15. McGraw-Hill Medical, New York
- Garcia-Bonafe M, Moragas A. (1996). Differential diagnosis of malignant and reactive cells from serous effusions: image and texture analysis study. Anal Cell Pathol, 12, 85-98.
- Hausheer F H, Yarbro J W (1987). Diagnosis and treatment of malignant pleural effusion. Cancer Metastasis Rev, 6, 23-40. https://doi.org/10.1007/BF00047607
- He T C, Zhou S, da Costa L T, et al. (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA, 95, 2509-14. https://doi.org/10.1073/pnas.95.5.2509
- Heffner J E, Klein J S (2008). Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clinic proceedings. Mayo Clinic, 83, 235-50. https://doi.org/10.1016/S0025-6196(11)60848-3
- Hemmi S, Geertsen R, Mezzacasa A, Peter I, Dummer R. (1998). The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther, 9, 2363-73. https://doi.org/10.1089/hum.1998.9.16-2363
- Henschke C I, Yankelevitz D F, Davis S D (1991). Pleural diseases: multimodality imaging and clinical management. Curr Probl Diagn Radiol, 20, 155-81. https://doi.org/10.1016/0363-0188(91)90020-3
- Holloway A J, Diyagama D S, Opeskin K, et al. (2006). A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Clin Cancer Res, 12, 5129-35. https://doi.org/10.1158/1078-0432.CCR-06-1027
- Kaner R J, Worgall S, Leopold P L, et al. (1999). Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/ adenovirus receptor. Am J Respir Cell Mol Biol, 20, 361-70. https://doi.org/10.1165/ajrcmb.20.3.3398
- Kanerva A, Mikheeva G V, Krasnykh V, et al. (2002). Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Clin Cancer Res, 8, 275-80.
- Kawakami Y, Li H, Lam J.T, et al. (2003). Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res, 63, 1262-9.
- Kuenen-Boumeester V, van Loenen P, de Bruijn E.M. and Henzen-Logmans S.C. (1996). Quality control of immunocytochemical staining of effusions using a standardized method of cell processing. Acta Cytol, 40, 475-9. https://doi.org/10.1159/000333902
- Lee J H, Chang J H (2005). Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest, 128, 2298-303. https://doi.org/10.1378/chest.128.4.2298
- Lyons M, Onion D, Green N.K, et al (2006). Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol Ther, 14, 118-28. https://doi.org/10.1016/j.ymthe.2006.01.003
- Martinez-Moragon E, Aparicio J, Sanchis J, et al. (1998). Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration, 65, 108-13. https://doi.org/10.1159/000029240
- Miller C R, Buchsbaum D J, Reynolds P N, et al (1998). Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptorindependent gene transfer. Cancer Res, 58, 5738-48.
- Motherby H, Kube M, Friedrichs N, et al. (1999). Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I. Prevalence of markers in tumour cell positive and negative smears. Anal Cell Pathol, 19, 7-20. https://doi.org/10.1155/1999/459158
- Motherby H, Pomjanski N, Kube M, et al. (2002). Diagnostic DNA-flow-vs. -image-cytometry in effusion cytology. Anal Cell Pathol, 24, 5-15. https://doi.org/10.1155/2002/840210
- Nalbantoglu J, Larochelle N, Wolf E, et al. (2001). Musclespecific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle. J Virol, 75, 4276-82. https://doi.org/10.1128/JVI.75.9.4276-4282.2001
- Nance K V, Shermer R W, Askin F B (1991), Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol, 4, 320-4.
- Northup J.K, Gadre S A, Ge Y, Lockhart L H Velagaleti G V (2007). Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition? Eur J Haematol, 78, 152-6.
- Osterheld MC, Liette C, Anca M. (2005). Image cytometry: an aid for cytological diagnosis of pleural effusions. Diagnostic cytopathology, 32, 173-6. https://doi.org/10.1002/dc.20205
- Porcel JM, Vives M, Esquerda A, et al. (2004). Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest, 126, 1757-63. https://doi.org/10.1378/chest.126.6.1757
- Shitrit D, Zingerman B, Shitrit A.B, Shlomi D, Kramer M R (2005). Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist, 10, 501-7. https://doi.org/10.1634/theoncologist.10-7-501
- Sriram K B, Relan V, Clarke B E, et al. (2011). Diagnostic molecular biomarkers for malignant pleural effusions. Future Oncol, 7, 737-52. https://doi.org/10.2217/fon.11.45
- Starr R.L. and Sherman M.E. (1991). The value of multiple preparations in the diagnosis of malignant pleural effusions. A cost-benefit analysis. Acta Cytol, 35, 533-7.
- Su X Y, Li G D, Liu W P, Xie B, Jiang YH (2011). Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagnostic cytopathology, 39, 900-8. https://doi.org/10.1002/dc.21489
- Takayama K, Reynolds P N, Short J J, et al (2003). A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology, 309, 282-93. https://doi.org/10.1016/S0042-6822(03)00067-9
- Westfall D E, Fan X, Marchevsky A M (2010). Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagnostic cytopathology, 38, 9-14.
- Woenckhaus M, Grepmeier U, Werner B, et al. (2005). Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology. J Mol Diagn, 7, 517-24. https://doi.org/10.1016/S1525-1578(10)60583-1
- Zabner J, Freimuth P, Puga A, Fabrega A, Welsh M,J (1997). Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J Clin Invest, 100, 1144-9. https://doi.org/10.1172/JCI119625